Reliability of a Portable Audiometric Device Based on Active Noise-Canceling Headphones for Clinical Hearing Assessment

Phase

N/A

Condition

Hearing Impairment

Hearing Loss

Deafness

Treatment

Participants were tested for hearing using a new type of hearing detection device

Participants' hearing was tested using a new portable pure tone audiometry device

Clinical Study ID

NCT06811610

KY20242145zhadingjun

Ages > 6
All Genders
Accepts Healthy Volunteers

Study Summary

Part One: Research Background Globally, approximately 500 million people suffer from disabling hearing loss, accounting for about 6.8% of the world's population. Hearing loss has emerged as a major global health issue. The cornerstone of hearing loss prevention and protection lies in hearing level testing. Early detection and intervention are crucial components of hearing healthcare. Currently, pure tone audiometry serves as the gold standard for hearing level testing, requiring patients to visit a hospital's standard soundproof room and complete the test under the guidance of a professional audiologist. However, existing professional audiometers are bulky, consume high power, and necessitate soundproof rooms (with background noise <30dBA), among other drawbacks. Moreover, primary hospitals or units lack professional audiologists and soundproof rooms, making it impossible to diagnose and treat hearing loss. Therefore, a portable hearing testing device that does not require a soundproof room would be a boon for the diagnosis and treatment of hearing loss patients. Currently, Wuhan Douting Technology Co., Ltd. has produced a portable hearing testing device (E200), supporting frequencies from 125Hz to 16000Hz, covering both conventional and extended high frequencies. The frequency tolerance, total harmonic distortion, and accuracy of hearing levels fully meet the technical requirements of Grade 4 audiometers according to national standards. In addition to meeting the functional and performance requirements of general audiometers, this device offers the following technical advantages and innovations: 1. Combining active and passive noise reduction, it achieves comprehensive noise reduction of over 29dBSPL, allowing for audiometry in environments with background noise <60dBA; 2. Supporting extended high frequencies, it can detect potential hearing damage earlier; 3. Supporting audiometry for rapid use by non-professionals, with automatic calibration, allowing non-professionals to operate by following prompts. This device is not yet on the market, and we intend to verify its reliability in assessing hearing conditions.

Part Two: Research Objectives To verify the reliability of a novel portable hearing testing device in assessing hearing conditions.

Part Three: Research Design Paired design

Part Four: Inclusion and Exclusion Criteria

Inclusion Criteria:

Age: ≥6 years old, no gender restriction Able to cooperate in completing pure tone audiometry

Exclusion Criteria:

Patients with acute otitis media or unremovable secretions blocking the external auditory canal Patients with mental or psychological disorders or unable to cooperate with the examination for other reasons

Part Five: Research Process This study will recruit volunteers from the outpatient and inpatient departments of Xijing Hospital. Each volunteer will undergo two audiological tests, with at least a 10-minute interval between the two tests to prevent intolerance to the hearing tests. Each audiological test will take approximately 6-8 minutes per subject.

Consultation and Physical Examination:

Researchers will collect general information, including name, gender, age, hearing status, and ear disease history; Conduct a physical examination of the ears; If a volunteer meets the inclusion criteria and voluntarily sign the informed consent form, researchers will determine the testing order using a random number method based on your enrollment sequence.

Conventional pure-tone audiometry:Patients undergo conventional pure tone audiometry using the interacoustics AC40 (Denmark) with TDH39 headphones (Telephonics; Farmingdale, NY, USA). We conducte audiometric testing in a sound-proof booth (background noise<30dBA) and evaluate the frequency range of 125-8000 Hz. Before the audiometry, patients will be asked to identify which ear have better hearing, and the ear with better hearing was tested first. This study employ the Hughson-Westlake approach, known as the " up-5 down-10 technique." The pure tone sound level was initially introduced at an estimated higher threshold and reduced by 10 dB HL after a correct response from the patient. If the patient did not respond correctly or at all, the sound level was increased by 5 dB HL. When there was a difference of 40 dB HL or more in air conduction thresholds between the ears, contralateral masking was applied to correct the cross-hearing.

E200 Audiometry: Noise-canceling headphones (RAN-3500) are used for all patients during the E200 audiometry. This is conducted in a regular room (ambient noise: 42.6-58.7 dBA, measured using a standard sound level meter: AWA6292 Multi-function Sound Level Meter) adjacent to a busy hallway without a sound-proof booth to simulate an ordinary environment. The Hughson-Westlake approach and contralateral masking are applied when conducting the E200 audiometry.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Age:≥6 years old, regardless of gender
Must be able to cooperate in completing pure tone audiometry

Exclusion

Exclusion Criteria:

Acute phase of otitis media or external ear canal within the secretion blockage cannot be removed
Those suffering from mental illness or other reasons unable to cooperate with thecompletion of the examination Remarks: Each participant was examined by a specialistusing otoscope. Those with ceruminous external auditory canal embolism or secretionblockage were cleared before audiological examination

Study Design

Participants were tested for hearing using a new type of hearing detection device

March 29, 2024

June 30, 2026

Study Description

Quality Control： Double-blind: The examiner does not have access to the results of the other testing technique until the experiment is completed, and the patient remains unaware of the results of both testing approaches until the end of the experiment.

Randomization: The sequence in which the patient undergoes the hearing tests is randomly determined using a random number table, ensuring an interval of at least 10 min between the two tests to avoid errors caused by fatigue or discomfort from consecutive testing.

Two individuals were responsible for entering the data, after which they verified each other's entries for accuracy.

Risks and Discomforts:

This study is a paired study utilizing a crossover trial method. All participants will undergo non-invasive procedures including basic information collection, medical history inquiry, physical examination, and pure tone audiometry. Pure tone audiometry, a standard outpatient clinical test, is conducted in a soundproof room. While this is a commonly used clinical examination method, an extremely small number of subjects may experience discomfort such as nervousness and anxiety due to不适应 to the enclosed environment. These symptoms can quickly subside once the subject leaves the environment and generally do not require special treatment. During the hearing test, pure tones are used. A minority of subjects with acoustic sensitivity may experience intolerance, ear pain, or other discomfort when exposed to louder sound stimuli. To mitigate this, the sound is gradually increased from a low volume during the examination. The researcher will closely monitor the subject's reactions, and if discomfort arises, the examination will be immediately halted. In most cases, symptoms will spontaneously resolve without special treatment after the examination is stopped. This study does not pose any additional risks to participants. For any adverse reactions that occur during the study, the researcher must accurately record them, promptly handle them according to medical protocols, and increase the frequency of follow-up visits or conduct additional laboratory tests based on the subject's condition. Follow-up should continue until the issue is properly resolved, the subject's condition stabilizes or returns to normal, or the researcher deems it appropriate to terminate follow-up.

Personal Information Confidentiality:

The information collected in this study will be kept confidential within the hospital as confidential material. To protect the identity of the subjects, any information related to the subjects in the research documents will be identified using a uniformly formatted number rather than names. Among all the collected and combined information of the subjects, any information that could help identify you will be removed to ensure that the relevant information cannot be linked to a specific research subject.

Sample Size Calculation： Based on the 69 data groups obtained in the pre-experiment, the Kappa coefficients were calculated as follows: left ear: 0.764, right ear: 0.743. A confidence level of 0.9 (α= 0.1) was used, and the confidence interval width was set to 0.2. The sample sizes computed using the PASS 2021 were determined to be 89 for the left ear and 107 for the right ear (eFigure 2 in Supplement 1). Ultimately, 114 patients were enrolled to validate the reliability of the E200.

Ethics： All patients provided written informed consent, and the study was approved by the Medical Ethics Committee of the First Affiliated Hospital of the Air Force Medical University(Ethics Committee FILE No: KY20242145-F-1). This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines .

Connect with a study center

The First Affiliated Hospital of the Air Force Medical University
Xi'an, Shanxi 710000
China
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.